Event JSON
{
"id": "f959e4dd123bedcac13c77a1a2a3fcea1a606096788068a3dcd14047ff6619ad",
"pubkey": "c6d131868bda14d54afb67f18acb3b8fd6f1e264f3d97966cf255ad4a4847744",
"created_at": 1702256908,
"kind": 1,
"tags": [
[
"p",
"3a447f2a7ed73bb761f6b312b3e523365e2954db30019d1b14a072546f41541e",
"wss://relay.mostr.pub"
],
[
"p",
"e774e44dec0cb77ae435efd8c93c51bba15e86846c566207577d4d3f7572bd40",
"wss://relay.mostr.pub"
],
[
"t",
"LongCovid"
],
[
"t",
"pwlc"
],
[
"t",
"postcovidsyndrome"
],
[
"t",
"lc"
],
[
"t",
"PASC"
],
[
"t",
"PostCovid"
],
[
"t",
"covidー19"
],
[
"t",
"COVID19"
],
[
"t",
"covid"
],
[
"t",
"COVID_19"
],
[
"t",
"sarscov2"
],
[
"t",
"covidbrain"
],
[
"proxy",
"https://disabled.social/users/tomkindlon/statuses/111559108737261765",
"activitypub"
]
],
"content": "A synbiotic preparation (SIM01) for post-acute COVID-19 syndrome in Hong Kong: a randomised, double-blind, placebo-controlled trial\n\nhttps://www.thelancet.com/journals/laninf/article/PIIS1473-3099(23)00685-0/fulltext\n\nAlways interesting to see results of trials like this that provide much better evidence than open label studies\n\nnostr:npub18fz872n76uamwc0kkvft8efrxe0zj4xmxqqe6xc55pe9gm6p2s0q9rhy22\n#LongCovid #PwLC #PostCovidSyndrome #LC #PASC #postcovid nostr:npub1ua6wgn0vpjmh4ep4alvvj0z3hws4ap5yd3txyp6h04xn7atjh4qq25gx9n \n#COVIDー19 #COVID19 #COVID #COVID_19 #SARSCoV2 #CovidBrain \n\n1/",
"sig": "336abdfc2b175182385a4b04490f01e58efbdc0003dcdb741f4beed5b7903d0ec75c5b8b6155bb4804b87d4586e26f9b679620b7836c41df83b0fb6eac28e243"
}